Optomed’s January–September 2022 interim report to be published on 3 November 2022
Optomed Plc Press Release 27 October 2022 at 9.00, Helsinki
Optomed’s January–September 2022 interim report to be published on 3 November 2022
Optomed will publish its January–September 2022 interim report on 3 November 2022 approximately at 9.00 EET.
A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest. The participants are requested to register for the call in advance by email to sakari.knuutti@optomed.com.
Please see the call-in numbers below:
FI +358 9 8562 6300
FR +33 1 70 99 53 92
SE +46 8 505 218 52
UK +44 20 3321 5273
US +1 646 838 1719
The conference id is 469 153 727#
Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.
Optomed Plc
Further enquiries
Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com, +358 50 562 4077
Optomed in Brief
Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company’s products are sold via various sales channels in over 60 countries globally